APA (7th ed.) Citation

AM, F., A, D., I, M., NJ, M., K, W., & TSK, E. (2022). Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma. Cellular oncology (Dordrecht, Netherlands), 45(6), 1277. https://doi.org/10.1007/s13402-022-00717-1

Chicago Style (17th ed.) Citation

AM, Fuller, DeVine A, Murazzi I, Mason NJ, Weber K, and Eisinger-Mathason TSK. "Comparative Oncology Reveals DNMT3B as a Molecular Vulnerability in Undifferentiated Pleomorphic Sarcoma." Cellular Oncology (Dordrecht, Netherlands) 45, no. 6 (2022): 1277. https://doi.org/10.1007/s13402-022-00717-1.

MLA (9th ed.) Citation

AM, Fuller, et al. "Comparative Oncology Reveals DNMT3B as a Molecular Vulnerability in Undifferentiated Pleomorphic Sarcoma." Cellular Oncology (Dordrecht, Netherlands), vol. 45, no. 6, 2022, p. 1277, https://doi.org/10.1007/s13402-022-00717-1.